55 results
8-K
EX-10.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor
8-K/A
EX-99.2
iztknw60vlng047uw
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
croh3or9wjt
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
w05zj
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
tlnjktd
10 May 23
Registration of securities issued in business combination transactions
9:56pm
8-K
EX-1.1
b4d7gqnky6fp0gkky
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-99.1
m91ne5
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
EX-99.1
gz5595c5d50u38mkugs
16 May 22
Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
2yeslnco1w3ygc
21 Mar 22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update
4:26pm